{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:51:14Z","timestamp":1760205074820,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.oftal.2020.05.014","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T17:44:22Z","timestamp":1593020662000},"page":"501-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Eficacia del implante de dexametasona intrav\u00edtreo en el manejo del \u00abs\u00edndrome de Vogt-Koyanagi-Harada-like\u00bb secundario a la inhibici\u00f3n de la v\u00eda MAP quinasa"],"prefix":"10.1016","volume":"95","author":[{"given":"R.","family":"Campos Polo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Garc\u00eda Guisado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rubio S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.T.","family":"M\u00e1rquez Ivacevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2020.05.014_bib0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/1758834014566428","article-title":"Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma","volume":"7","author":"Welsh","year":"2015","journal-title":"Ther Adv Med Oncol."},{"key":"10.1016\/j.oftal.2020.05.014_bib0060","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejca.2013.10.016","article-title":"Ocular adverse events of molecularly targeted agents approved in solid tumours: A systematic review","volume":"50","author":"Huillard","year":"2014","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.oftal.2020.05.014_bib0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/09273948.2016.1261166","article-title":"Bilateral ischemic retinal vasculitis in metastatic cutaneous melanoma patient treated with dabrafenib and trametinib: A case report","volume":"26","author":"Niro","year":"2018","journal-title":"Ocul Immunol Inflamm."},{"key":"10.1016\/j.oftal.2020.05.014_bib0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.oftal.2020.05.014_bib0075","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/OPTH.S181256","article-title":"Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis","volume":"12","author":"Tufail","year":"2018","journal-title":"Clin Ophthalmol."},{"key":"10.1016\/j.oftal.2020.05.014_bib0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.oftal.2020.05.014_bib0085","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/annonc\/mdw100","article-title":"Ocular toxicities of MEK inhibitors and other targeted therapies","volume":"27","author":"Stjepanovic","year":"2016","journal-title":"Ann Oncol."},{"key":"10.1016\/j.oftal.2020.05.014_bib0090","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ophtha.2017.05.038","article-title":"Clinical and morphologic characteristics of MEK inhibitor-associated retinopathy: Differences from central serous chorioretinopathy","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftal.2020.05.014_bib0095","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.ophtha.2012.02.021","article-title":"Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy","volume":"119","author":"Jirarattanasopa","year":"2012","journal-title":"Ophthalmology."},{"issue":"Suppl 1","key":"10.1016\/j.oftal.2020.05.014_bib0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12886-018-0861-8","article-title":"New features in MEK retinopathy","volume":"18","author":"Tyagi","year":"2018","journal-title":"BMC Ophthalmol."}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036566912030191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036566912030191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:44:15Z","timestamp":1759794255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036566912030191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S036566912030191X"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2020.05.014","relation":{},"ISSN":["0365-6691"],"issn-type":[{"type":"print","value":"0365-6691"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eficacia del implante de dexametasona intrav\u00edtreo en el manejo del \u00abs\u00edndrome de Vogt-Koyanagi-Harada-like\u00bb secundario a la inhibici\u00f3n de la v\u00eda MAP quinasa","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2020.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}